Clinical Trial Update: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating B007 for primary membranous nephropathy is currently recruiting, sponsored by Shanghai Jiaolian Drug Research and Developm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• B007

Snippet

Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd | Conditions: Primary Membranous Nephropathy | Phase 2, Phase 3 | Status: RECRUITING